4/1/2024 | BK | Haemonetics to draw $150 million under revolver to finance acquisition
|
3/5/2024 | BK | Haemonetics to draw on revolver for Advanced Cooling acquisition
|
12/12/2023 | BK | Haemonetics draws down $110 million for OpSens acquisition
|
8/1/2022 | BK | Haemonetics gets $700 million three-year credit facility in two parts
|
5/13/2021 | CV | Market Commentary: Fluor convertible preferreds, Braemar eyed; DraftKings notes weaker in active trading
|
4/20/2021 | CV | Market Commentary: Greenbrier down outright, up dollar-neutral; Haemonetics trends lower; j2 Global active
|
4/20/2021 | CV | Market Commentary: Morning Commentary: Convertibles secondary space quiet; Haemonetics notes active early
|
4/19/2021 | CV | Market Commentary: Investment-grade convertibles active; Haemonetics tanks outright; Peloton improves
|
3/16/2021 | CV | Haemonetics greenshoe exercised, ups convertibles to $500 million
|
3/3/2021 | CV | Market Commentary: Tyler Technologies, Cutera, AES offerings on tap; new convertible notes under pressure
|
3/3/2021 | CV | Market Commentary: Morning Commentary: Airbnb, RealReal convertibles eyed; supply floods the secondary
|
3/2/2021 | CV | New Issue: Haemonetics sells $435 million five-year convertible notes to yield 0%, up 40%
|
3/2/2021 | CV | Market Commentary: Convertibles primary on fire; $3.23 billion in six deals on deck; Twitter below par
|
3/2/2021 | CV | Market Commentary: Morning Commentary: Convertibles primary on fire; $3.23 billion in six deals on deck
|
3/1/2021 | CV | Market Commentary: Primary markets $4.1 billion convertibles in eight deals; Twitter, Shake Shack eyed
|
3/1/2021 | BK | Haemonetics adds $150 million of term loans via accordion
|
3/1/2021 | CV | Haemonetics talks $425 million five-year convertible notes to yield 0%-0.5%, up 40%-45%
|
6/26/2019 | SP | New Issue: CIBC sells $133,000 notes tied to 14 Raymond James Healthcare top picks
|
6/26/2019 | SP | New Issue: CIBC sells $253,000 notes tied to 14 Raymond James Healthcare top picks
|
6/7/2019 | SP | CIBC plans Raymond James Healthcare Top Selections notes on 14 stocks
|
6/7/2019 | SP | CIBC eyes Raymond James Healthcare Top Selections notes on 14 stocks
|
6/18/2018 | BK | Haemonetics secures $350 million term loan A, $350 million revolver
|
6/19/2017 | HYIG | Haemonetics pays off $93 million of debt, touts strong balance sheet
|
7/7/2014 | BK | Haemonetics enters amended $480 million term loan, revolver due 2019
|
8/7/2012 | BK | Haemonetics gets $525 million credit facility at Libor plus 137.5 bps
|
5/3/2012 | BK | Haemonetics $525 million facility to include $50 million revolver
|
4/30/2012 | BK | Haemonetics plans $475 million term loans for acquisition financing
|
8/10/2006 | BT | Haemonetics to buy back up to $40 million of common stock
|
8/8/2006 | BT | Haemonetics, Canadian Blood Services sign supply agreement
|
6/8/2006 | BT | Haemonetics to acquire remaining shares of Arryx for $26 million
|
5/4/2006 | BT | Market Commentary: Bausch & Lomb stock sinks after buyback offering to avoid default; ImmunoGen stock up on earnings
|
10/27/2005 | BT | Haemonetics amends agreement with Arryx for expanded field of use
|
10/27/2005 | BT | Haemonetics' Harmony pump gains FDA marketing clearance
|